Jazz Pharmaceuticals plc (JAZZ)
NASDAQ · Healthcare
Jazz Pharmaceuticals plc Net Income 2009–2025
Jazz Pharmaceuticals plc annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Jazz Pharmaceuticals plc net income for the quarter ending March 31, 2026 was 293.1 M, a 416.86% decrease year-over-year.
- Jazz Pharmaceuticals plc net income for the twelve months ending March 31, 2026 was -266.5 M, a 151.66% decrease year-over-year.
- Jazz Pharmaceuticals plc annual net income for 2025 was -356.1 M, a 163.58% decrease from 2024.
- Jazz Pharmaceuticals plc annual net income for 2024 was 560.1 M, a 35.02% increase from 2023.
- Jazz Pharmaceuticals plc annual net income for 2023 was 414.8 M, a 285.14% decrease from 2022.
- Jazz Pharmaceuticals plc annual net income for 2022 was -224.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jazz Pharmaceuticals plc Net Income — FAQ
Jazz Pharmaceuticals plc (JAZZ) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Jazz Pharmaceuticals plc's net income?
Jazz Pharmaceuticals plc (JAZZ) reported net income of -$356M for fiscal 2025.
Where can I see JAZZ's net income history?
The chart and table above show Jazz Pharmaceuticals plc's net income by year and by quarter, including the growth rate.